Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin versus gliclazide for renal hemodynamics in metformin-treated type 2 diabetes
NL-OMON47241Phase 4Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing Dapagliflozin arm with Gliclazide arm (2 arms). Primary endpoint: Long-term effect on renal hemodynamics. Started Feb 2016; status: active, not recruiting.
02
Drugs
dapagliflozingliclazide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON47241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47241.